Recent advances in the epidemiology, prevention and treatment of invasive fungal infections in neutropenic patients.
Walsh
T J
TJ
Section of Infectious Diseases, National Cancer Institute, Bethesda, Maryland.
De Pauw
B
B
Anaissie
E
E
Martino
P
P
D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D002177:Candidiasis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications; D009894:Opportunistic Infections / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy
D000935:Antifungal Agents